Related Experiment Video
Updated: Feb 20, 2026

11:13
Mass Spectrometry-Guided Genome Mining as a Tool to Uncover Novel Natural Products
Published on: March 12, 2020
11.6K
Discovery of lucensimycins A and B from Streptomyces lucensis MA7349 using an antisense strategy
Sheo B Singh1, Deborah L Zink, Joanne Huber
1Merck Research Laboratories, Rahway, New Jersey 07065, USA. sheo_singh@merck.com
Organic Letters
|November 17, 2006
Abstract:
Inhibition of protein synthesis is one of the validated and highly successful targets for inhibition of bacterial growth; this mechanism is a target of a large number of clinical drugs. Ribosomal protein S4, a primary protein, is a potential target for the discovery of antibacterial agents. We describe, using an antisense-sensitized rpsD Streptomyces aureus strain, the discovery and activity of lucensimycins A and B. [structure: see text].

